These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10864115)

  • 1. Glycohistochemical characteristics of nasal polyps from patients with and without cystic fibrosis.
    Hassid S; Choufani G; Decaestecker C; Delbrouck C; Dawance S; Pelc P; Nagy N; Kaltner H; Salmon I; Danguy A; Gabius HJ; Kiss R
    Arch Otolaryngol Head Neck Surg; 2000 Jun; 126(6):769-76. PubMed ID: 10864115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative glycohistochemical characterization of normal nasal mucosa, and of single as opposed to massive nasal polyps.
    Hassid S; Choufani G; Nagy N; Kaltner H; Danguy A; Gabius HJ; Kiss R
    Ann Otol Rhinol Laryngol; 1999 Aug; 108(8):797-805. PubMed ID: 10453790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemical study of the epithelia of nasal polyps by biotinylated lectins and neoglycoprotein. A comparison with the normal human respiratory epithelium.
    Hassid S; Salmon I; Brugmans M; Dawance S; Kiss R; Gabius HJ; Danguy A
    Eur J Morphol; 1997 Apr; 35(2):79-86. PubMed ID: 9253585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Algorithm analysis of lectin glycohistochemistry and Feulgen cytometry for a new classification of nasal polyposis.
    Hassid S; Decaestecker C; Hermans C; Salmon I; Pasteels JL; Danguy A; Kiss R
    Ann Otol Rhinol Laryngol; 1997 Dec; 106(12):1043-51. PubMed ID: 9415600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis.
    Derycke L; Zhang N; Holtappels G; Dutré T; Bachert C
    J Cyst Fibros; 2012 May; 11(3):193-200. PubMed ID: 22178076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Bcl-2 in nasal polyps from patients with cystic fibrosis.
    Scapa VI; Ramakrishnan VR; Kingdom TT
    Int Forum Allergy Rhinol; 2013 Mar; 3(3):199-203. PubMed ID: 23135964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degranulation of cystic fibrosis nasal polyp mast cells.
    Henderson WR; Chi EY
    J Pathol; 1992 Apr; 166(4):395-404. PubMed ID: 1517893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.
    Rozsasi A; Heinemann A; Keck T
    Am J Rhinol Allergy; 2011; 25(6):e251-4. PubMed ID: 22185734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium.
    Dupuit F; Kälin N; Brézillon S; Hinnrasky J; Tümmler B; Puchelle E
    J Clin Invest; 1995 Sep; 96(3):1601-11. PubMed ID: 7544810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology of nasal polyps of different etiology.
    Sorensen H; Mygind N; Tygstrup I; Winge Flensborg E
    Rhinology; 1977 Sep; 15(3):121-8. PubMed ID: 905718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators.
    Claeys S; Van Hoecke H; Holtappels G; Gevaert P; De Belder T; Verhasselt B; Van Cauwenberge P; Bachert C
    Clin Exp Allergy; 2005 Apr; 35(4):467-72. PubMed ID: 15836755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ultrastructure of the nasal polyps in patients with and without cystic fibrosis.
    Beju D; Meek WD; Kramer JC
    J Submicrosc Cytol Pathol; 2004 Apr; 36(2):155-65. PubMed ID: 15554502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide induction of cyclooxygenase-2 in long-term nasal epithelial cultures in cystic fibrosis.
    Rozsasi A; Keck T
    Arch Otolaryngol Head Neck Surg; 2010 Apr; 136(4):335-9. PubMed ID: 20403848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of RANTES in nasal polyps from patients with cystic fibrosis.
    Scapa VI; Ramakrishnan VR; Mudd PA; Kingdom TT
    Int Forum Allergy Rhinol; 2011; 1(3):157-60. PubMed ID: 22287365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal polyps in cystic fibrosis.
    Tos M; Mogensen C; Thomsen J
    J Laryngol Otol; 1977 Oct; 91(10):827-35. PubMed ID: 925492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of proliferative activity in nasal polyps.
    Hassid S; Degaute MP; Dawance S; Rombaut K; Nagy N; Choufani G; Decaestecker C; Danguy A; Salmon I; Kiss R
    J Clin Pathol; 1997 Nov; 50(11):923-8. PubMed ID: 9462241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology of nasal polyps in cystic fibrosis: not a unimodal disease.
    Steinke JW; Payne SC; Chen PG; Negri J; Stelow EB; Borish L
    Ann Otol Rhinol Laryngol; 2012 Sep; 121(9):579-86. PubMed ID: 23012896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of inflammation- and neoplasia-associated alterations in human large intestine using plant/invertebrate lectins, galectin-1 and neoglycoproteins.
    Brinck U; Korabiowska M; Bosbach R; Gabius HJ
    Acta Anat (Basel); 1998; 161(1-4):219-33. PubMed ID: 9780361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of expression of galectin-7 in human nasal polyps by budesonide.
    Delbrouck C; Souchay C; Kaltner H; André S; Gabius HJ; Vandenhoven G; Hassid S
    B-ENT; 2005; 1(3):137-44. PubMed ID: 16255498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.